trans-4-((2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-4-yl)amino)cyclohexanol

Catalog No. :
ACMEVX394
CAS No. :
1497419-90-5
Molecular Formula :
C16H25BClN3O3
Molecular Weight :
353.66

IUPAC Name:(1r,4r)-4-((2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-4-yl)amino)cyclohexan-1-ol

trans-4-((2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-4-yl)amino)cyclohexanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametrans-4-((2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-4-yl)amino)cyclohexanol
IUPAC Name(1r,4r)-4-((2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-4-yl)amino)cyclohexan-1-ol
Molecular FormulaC16H25BClN3O3
Molecular Weight353.66
SMILESO[C@H]1CC[C@H](NC2=NC(Cl)=NC=C2B3OC(C)(C)C(C)(C)O3)CC1
InChI KeyXADHMZNFFIYIHJ-XYPYZODXSA-N
SynonymCyclohexanol, 4-[[2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-pyrimidinyl]amino]-, trans-
CAS No.1497419-90-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMEVX394 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMEVX394 route product structure diagram
    ACMEVX3941497419-90-5
Inquiry

2. ACMEVX394 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMEVX394 route product structure diagram
    ACMEVX3941497419-90-5
Inquiry

Comments (0)